Ready Med review

Ready Med’s semaglutide page (opens in a new tab) advertises $99 for the first month and $199 each month afterward, including provider care and medication when prescribed. Its FAQ also describes an extra $100 per month for a specified higher-dose option and for an alternative monthly-shipment program. The headline should not be treated as a confirmed price for every dose and delivery schedule.

The tirzepatide page (opens in a new tab) displays both $297 and $449 per month. The oral semaglutide page (opens in a new tab) similarly shows $249 near the top and $297 elsewhere. Ask for a written quote naming the drug, route, supplied amount and all charges. Our provider cost checklist explains what to compare.

The homepage (opens in a new tab) promotes a four-week introductory semaglutide supply with a $99 clinician charge and says there are no recurring payments or card on file. Other pages describe a monthly membership. The terms (opens in a new tab) instruct patients to contact the office manager to arrange refill consultations. These descriptions do not establish one clear renewal arrangement.

The injection page also says shipments may cover 60 or 90 days despite monthly payments. Ask when each charge occurs, how much usable medication each shipment contains and what stops the next order. A shipment covering several months is different from a prepaid contract; our monthly versus four-week billing guide separates those questions.

The FAQ (opens in a new tab) says every client speaks with a provider by two-way video and that appointment assignments depend on state licensing and availability. It describes third-party compounding pharmacies shipping prescribed medication directly. The pages reviewed do not identify the dispensing pharmacy for a particular patient.

The FAQ allows a prescription to be sent to another pharmacy, but warns that the advertised program pricing may not apply there. Confirm the clinician, dispensing pharmacy and state eligibility before paying. The FAQ’s state-availability question does not actually provide a state list, so it cannot support a nationwide-access claim.

Product pages advertise a 30-day satisfaction refund, and the FAQ says patients who are not appropriate candidates receive their payment back. However, the terms of use (opens in a new tab) state that consultations, medication and other services are subject to a strict no-refund policy. The reviewed pages do not reconcile those statements.

Cancellation instructions also differ: the FAQ says patients can cancel through the website, while the injection page directs them to email. Request the applicable refund exception and cancellation deadline in writing before authorizing payment. Our GLP-1 cancellation and refund guide distinguishes stopping future billing from recovering money already paid.

An FDA warning letter dated June 8, 2026 (opens in a new tab), reference 730317, identifies Ready Med and readymednow.com. FDA challenged promotional representations about compounded semaglutide and tirzepatide, including how their source and regulatory status were presented. This is a dated finding; it does not establish current remediation or closeout.

Compounded medications are not FDA-approved. Read our compounded-medication guide alongside the letter. Ready Med’s published video-care process may help patients understand how consultation works, but the unresolved price and refund terms deserve clarification before enrollment.